|
|
???tair.name??? >
???browser.page.title.author???
|
"rau k m"???jsp.browse.items-by-author.description???
Showing items 26-38 of 38 (2 Page(s) Totally)
<< < 1 2
View [10|25|50] records per page
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 國立成功大學 |
2019 |
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Zhu, A.X.;Kang, Y.-K.;Yen, C.-J.;Finn, R.S.;Galle, P.R.;Llovet, J.M.;Assenat, E.;Brandi, G.;Pracht, M.;Lim, H.Y.;Rau, K.-M.;Motomura, K.;Ohno, I.;Merle, P.;Daniele, B.;Shin, D.B.;Gerken, Gerken G.;Borg, C.;Hiriart, J.-B.;Okusaka, T.;Morimoto, Morimoto M.;Hsu, Y.;Abada, P.B.;Kudo, M.;investigators, REACH-2 study |
| 國立成功大學 |
2018 |
Gender difference in cancer patients' adherence to analgesics and related outcomes of pain management
|
Chou, P.-L.;Fang, S.-Y.;Sun, J.-L.;Rau, K.-M.;Lee, B.-O. |
| 國立成功大學 |
2018 |
Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan
|
Rau, K.-M.;Ou-Yang, F.;Chao, T.-C.;Kuo, Y.-L.;Cheng, T.-F.;Chao, T.-Y.;Chen, D.-R.;Tzeng, Y.-D.;Wang, B.-W.;Liu, C.-Y.;Hu, M.-H.;Lu, Y.-C.;Ou, W.-J.;Kuo, C.-H.;Chuang, Chuang C.-H.;Kan, J.-Y.;Chen, F.-M.;Hou, M.-F. |
| 國立成功大學 |
2017 |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen, W.-C.;Chen, J.-S.;Shao, Y.-Y.;Lee, K.-D.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Liao, Y.-M.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Chou, W.-C.;Hsieh, R.-K. |
| 國立成功大學 |
2015-12-01 |
A clinical survey on satisfaction of pain management in hospitalized patients with cancer in Taiwan
|
Lin, J.; Chang, C. -S.; Lee, M. -Y.; Liao, Y. -M.; Wu, M. -F.; Sung, Y. -C.; Rau, K. -M.; Yu, M. -S.; Lai, P. -Y.; Chiou, T. -J.; Chen, J. -S.; Lee, K. -D.; Hwang, W. -L.; Liu, T. -C.; Yen, C. -J.; Shao, Y. -Y.; Hsieh, R. -K. |
| 國立成功大學 |
2015-12-01 |
Impact and predictive factor of undertreatment of analgesic drug in outpatients with cancer: a nationwide of clinical pain survey in Taiwan
|
Yang, C. -K.; Chou, W. -C.; Shen, W. -C.; Chen, J. -S.; Lee, K. -D.; Yen, C. -J.; Lai, P. -Y.; Shao, Y. -Y.; Hwang, W. -L.; Chiou, T. -J.; Sung, Y. -C.; Rau, K. -M.; Liao, Y. -M.; Chang, C. S.; Wu, M. -F.; Lee, M. -Y.; Yu, M. -S.; Liu, T. -C.; Hsieh, R. -K. |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 臺大學術典藏 |
2015 |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Cheng A.-L.; Shih T.T.-F.; CHIUN-SHENG HUANG; Huang S.-M.; Chao T.-C.; Chen B.-B.; Rau K.-M.; Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2015 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
on behalf of the Taiwan Cooperative Oncology Group; Wei T.-C.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Chang J.Y.; Yu M.S.; Yang Y.; Hsieh R.K.; Chiu C.F.; Rau K.M.; Lee K.D.; Shiah H.S.; Chang I.C.; Bai L.Y.; Huang S.F.; Tsou H.H.; Tsai C.S.; Chiang N.J.; CHIH-HUNG HSU; Chen J.S.; Chen J.S.;Chih-Hung Hsu;Chiang N.J.;Tsai C.S.;Tsou H.H.;Huang S.F.;Bai L.Y.;Chang I.C.;Shiah H.S.;Ho C.L.;Yen C.J.;Lee K.D.;Chiu C.F.;Rau K.M.;Yu M.S.;Yang Y.;Hsieh R.K.;Chang J.Y.;Shan Y.S.;Chao Y.;Chen L.-T.;Chin Y.-H.;Chung T.-R.;Yu W.-L.;Lee M.-H.;Lin L.-F.;Lin P.-C.;Wu Y.-L.;Wang H.-L.;Lu L.-J.;Chen S.-Y.;Wu C.-C.;Wei T.-C.;On Behalf Of The Taiwan Cooperative Oncology Group; Yen C.J.; Ho C.L. |
| 亞洲大學 |
2006-07 |
Mutant Bik expression mediated by the enhanced minimal Topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model
|
Day, C-P.;Rau, K-M.;Qiu, L.;Liu, C-W.;Kuo, H-P.;Xie, X.;Lopez-Berestein, G.;Hortobagyi, G. N.;Mien-Chie Hung |
| 亞洲大學 |
2004-11 |
Cancer-specific activation of the survivin promoter and its potential use in gene therapy
|
Chen, J-S.;Liu, J-C.;Shen, L.;Rau, K-M.;Kuo, H-P.;Li, Y. M.;Shi, D.;Lee, Y-C.;Chang, K-J.;Mien-Chie Hung |
| 臺大學術典藏 |
2004 |
Cancer-specific activation of the survivin promoter and its potential use in gene therapy
|
Hung M.-C.; Chang K.-J.; Shi D.; Lee Y.-C.; Li Y.M.; Kuo H.-P.; Rau K.-M.; Shen L.; Liu J.-C.; JIN-SHING CHEN; Jin-Shing Chen;Liu J.-C.;Shen L.;Rau K.-M.;Kuo H.-P.;Li Y.M.;Shi D.;Lee Y.-C.;Chang K.-J.;Hung M.-C. |
Showing items 26-38 of 38 (2 Page(s) Totally)
<< < 1 2
View [10|25|50] records per page
|
